Eva Randárová

512 total citations
29 papers, 432 citations indexed

About

Eva Randárová is a scholar working on Biomaterials, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Eva Randárová has authored 29 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomaterials, 7 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Eva Randárová's work include Nanoparticle-Based Drug Delivery (16 papers), Advanced Polymer Synthesis and Characterization (6 papers) and Dendrimers and Hyperbranched Polymers (4 papers). Eva Randárová is often cited by papers focused on Nanoparticle-Based Drug Delivery (16 papers), Advanced Polymer Synthesis and Characterization (6 papers) and Dendrimers and Hyperbranched Polymers (4 papers). Eva Randárová collaborates with scholars based in Czechia, Japan and France. Eva Randárová's co-authors include Tomáš Etrych, Petr Chytil, Karel Ulbrich, Olga Janoušková, Hideaki Nakamura, Jun Fang, Hiroshi Maeda, Libor Kostka, Mamoru Haratake and Rafał Konefał and has published in prestigious journals such as Journal of Controlled Release, Nanoscale and Acta Biomaterialia.

In The Last Decade

Eva Randárová

29 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Randárová Czechia 13 258 194 134 97 60 29 432
Fabiana Canal Spain 7 329 1.3× 176 0.9× 205 1.5× 114 1.2× 70 1.2× 8 514
Yongjun Wang China 5 223 0.9× 242 1.2× 197 1.5× 52 0.5× 37 0.6× 13 472
Jixue Wang China 12 277 1.1× 259 1.3× 142 1.1× 48 0.5× 23 0.4× 23 536
E. Yu. Moskaleva Russia 7 178 0.7× 82 0.4× 140 1.0× 79 0.8× 23 0.4× 37 390
Aida Varela-Moreira Netherlands 12 274 1.1× 149 0.8× 202 1.5× 77 0.8× 38 0.6× 16 507
Hayley Nehoff New Zealand 3 272 1.1× 221 1.1× 165 1.2× 37 0.4× 30 0.5× 3 466
Annalisa Ferrero Italy 5 173 0.7× 92 0.5× 160 1.2× 35 0.4× 30 0.5× 5 359
Minyi Lei China 9 175 0.7× 209 1.1× 114 0.9× 21 0.2× 28 0.5× 11 438
Rahul Nahire United States 9 180 0.7× 221 1.1× 102 0.8× 39 0.4× 20 0.3× 10 389

Countries citing papers authored by Eva Randárová

Since Specialization
Citations

This map shows the geographic impact of Eva Randárová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Randárová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Randárová more than expected).

Fields of papers citing papers by Eva Randárová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Randárová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Randárová. The network helps show where Eva Randárová may publish in the future.

Co-authorship network of co-authors of Eva Randárová

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Randárová. A scholar is included among the top collaborators of Eva Randárová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Randárová. Eva Randárová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanctis, Juan Bautista De, Lukáš Kubala, Petr Chytil, et al.. (2024). Polymer nanotherapeutics with the controlled release of acetylsalicylic acid and its derivatives inhibiting cyclooxygenase isoforms and reducing the production of pro-inflammatory mediators. International Journal of Pharmaceutics. 665. 124742–124742. 2 indexed citations
2.
Randárová, Eva, Lukáš Kubala, Rafał Konefał, et al.. (2024). Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases. International Journal of Pharmaceutics. 654. 123979–123979. 1 indexed citations
3.
Špringer, Tomáš, Rafał Konefał, Tomáš Křížek, et al.. (2023). Using surface plasmon resonance, capillary electrophoresis and diffusion-ordered NMR spectroscopy to study drug release kinetics. Communications Chemistry. 6(1). 180–180. 8 indexed citations
4.
Randárová, Eva, et al.. (2023). Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis. Nanomedicine Nanotechnology Biology and Medicine. 55. 102716–102716. 6 indexed citations
5.
Filipová, Marcela, et al.. (2022). The Transmission and Toxicity of Polymer-Bound Doxorubicin-Containing Exosomes Derived from Human Adenocarcinoma Celxdls. Nanomedicine. 17(19). 1307–1322. 2 indexed citations
6.
Randárová, Eva, et al.. (2022). Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis. Journal of Controlled Release. 353. 30–41. 9 indexed citations
7.
Kostka, Libor, Eva Randárová, Carolina A. Ferreira, et al.. (2022). Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models. Journal of Controlled Release. 353. 549–562. 6 indexed citations
8.
Sivák, Ladislav, Vladimír Šubr, Milada Šírová, et al.. (2021). Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling. Journal of Controlled Release. 332. 563–580. 12 indexed citations
9.
Randárová, Eva, Hideaki Nakamura, Martin Studenovský, et al.. (2020). Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization. Acta Biomaterialia. 106. 256–266. 22 indexed citations
10.
Randárová, Eva, et al.. (2020). HPMA copolymer-antibody constructs in neoplastic treatment: an overview of therapeutics, targeted diagnostics, and drug-free systems. Journal of Controlled Release. 325. 304–322. 13 indexed citations
11.
Randárová, Eva, et al.. (2020). Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation. Pharmaceutics. 12(8). 700–700. 13 indexed citations
12.
Liu, Jianhua, Thomas J. L’Ecuyer, Yohann Corvis, et al.. (2020). Coating Persistent Luminescence Nanoparticles With Hydrophilic Polymers for in vivo Imaging. Frontiers in Chemistry. 8. 584114–584114. 11 indexed citations
13.
Randárová, Eva, et al.. (2018). Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers. European Journal of Pharmaceutics and Biopharmaceutics. 131. 141–150. 7 indexed citations
14.
Chytil, Petr, Eva Randárová, Tomáš Etrych, & Karel Ulbrich. (2018). Macromol. Biosci. 1/2018. Macromolecular Bioscience. 18(1). 2 indexed citations
15.
Randárová, Eva, Petr Chytil, Tomáš Etrych, & Olga Janoušková. (2017). Ability of polymer-bound P-glycoprotein inhibitor ritonavir to overcome multidrug resistance in various resistant neuroblastoma cell lines. Anti-Cancer Drugs. 28(10). 1126–1130. 6 indexed citations
16.
Randárová, Eva, Olga Janoušková, Lucie Cuchalová, et al.. (2016). Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. Journal of Controlled Release. 233. 136–146. 31 indexed citations
17.
Nakamura, Hideaki, Eva Randárová, Petr Chytil, et al.. (2016). Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Molecular Pharmaceutics. 13(12). 4106–4115. 37 indexed citations
18.
Šubr, Vladimír, Eva Randárová, Ladislav Sivák, et al.. (2015). Polymer inhibitors of ABC transporter overcoming multidrug resistance: Synthesis, characterization and in vitro evaluation. Journal of Controlled Release. 213. e107–e108. 5 indexed citations
19.
Rabišková, Miloslava, et al.. (2014). Nanoparticulates with drug release based on temperature change. Česká a slovenská farmacie. 63(6). 239–247. 1 indexed citations
20.
Nakamura, Hideaki, Eva Randárová, Tomáš Etrych, et al.. (2014). Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice. European Journal of Pharmaceutics and Biopharmaceutics. 90. 90–96. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiana Canal Breakdown of academic impact, for papers by Yongjun Wang Breakdown of academic impact, for papers by Jixue Wang Breakdown of academic impact, for papers by E. Yu. Moskaleva Breakdown of academic impact, for papers by Aida Varela-Moreira Breakdown of academic impact, for papers by Hayley Nehoff Breakdown of academic impact, for papers by Annalisa Ferrero Breakdown of academic impact, for papers by Minyi Lei Breakdown of academic impact, for papers by Rahul Nahire
Rankless by CCL
2026